Embla Medical hf
CSE:EMBLA

Watchlist Manager
Embla Medical hf Logo
Embla Medical hf
CSE:EMBLA
Watchlist
Price: 35.9 DKK -1.1% Market Closed
Market Cap: 15.3B DKK
Have any thoughts about
Embla Medical hf?
Write Note

Intrinsic Value

The intrinsic value of one EMBLA stock under the Base Case scenario is 39.12 DKK. Compared to the current market price of 35.9 DKK, Embla Medical hf is Undervalued by 8%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

EMBLA Intrinsic Value
39.12 DKK
Undervaluation 8%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Embla Medical hf

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for EMBLA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about EMBLA?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Embla Medical hf

Provide an overview of the primary business activities
of Embla Medical hf.

What unique competitive advantages
does Embla Medical hf hold over its rivals?

What risks and challenges
does Embla Medical hf face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Embla Medical hf.

Provide P/S
for Embla Medical hf.

Provide P/E
for Embla Medical hf.

Provide P/OCF
for Embla Medical hf.

Provide P/FCFE
for Embla Medical hf.

Provide P/B
for Embla Medical hf.

Provide EV/S
for Embla Medical hf.

Provide EV/GP
for Embla Medical hf.

Provide EV/EBITDA
for Embla Medical hf.

Provide EV/EBIT
for Embla Medical hf.

Provide EV/OCF
for Embla Medical hf.

Provide EV/FCFF
for Embla Medical hf.

Provide EV/IC
for Embla Medical hf.

Show me price targets
for Embla Medical hf made by professional analysts.

What are the Revenue projections
for Embla Medical hf?

How accurate were the past Revenue estimates
for Embla Medical hf?

What are the Net Income projections
for Embla Medical hf?

How accurate were the past Net Income estimates
for Embla Medical hf?

What are the EPS projections
for Embla Medical hf?

How accurate were the past EPS estimates
for Embla Medical hf?

What are the EBIT projections
for Embla Medical hf?

How accurate were the past EBIT estimates
for Embla Medical hf?

Compare the revenue forecasts
for Embla Medical hf with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Embla Medical hf and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Embla Medical hf against its competitors.

Analyze the profit margins
(gross, operating, and net) of Embla Medical hf compared to its peers.

Compare the P/E ratios
of Embla Medical hf against its peers.

Discuss the investment returns and shareholder value creation
comparing Embla Medical hf with its peers.

Analyze the financial leverage
of Embla Medical hf compared to its main competitors.

Show all profitability ratios
for Embla Medical hf.

Provide ROE
for Embla Medical hf.

Provide ROA
for Embla Medical hf.

Provide ROIC
for Embla Medical hf.

Provide ROCE
for Embla Medical hf.

Provide Gross Margin
for Embla Medical hf.

Provide Operating Margin
for Embla Medical hf.

Provide Net Margin
for Embla Medical hf.

Provide FCF Margin
for Embla Medical hf.

Show all solvency ratios
for Embla Medical hf.

Provide D/E Ratio
for Embla Medical hf.

Provide D/A Ratio
for Embla Medical hf.

Provide Interest Coverage Ratio
for Embla Medical hf.

Provide Altman Z-Score Ratio
for Embla Medical hf.

Provide Quick Ratio
for Embla Medical hf.

Provide Current Ratio
for Embla Medical hf.

Provide Cash Ratio
for Embla Medical hf.

What is the historical Revenue growth
over the last 5 years for Embla Medical hf?

What is the historical Net Income growth
over the last 5 years for Embla Medical hf?

What is the current Free Cash Flow
of Embla Medical hf?

Discuss the annual earnings per share (EPS)
trend over the past five years for Embla Medical hf.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Embla Medical hf

Current Assets 401.5m
Cash & Short-Term Investments 81.2m
Receivables 129.6m
Other Current Assets 190.7m
Non-Current Assets 1.2B
Long-Term Investments 27m
PP&E 200m
Intangibles 908.7m
Other Non-Current Assets 45.3m
Current Liabilities 201.6m
Accounts Payable 29.4m
Accrued Liabilities 46.7m
Other Current Liabilities 125.5m
Non-Current Liabilities 597.1m
Long-Term Debt 488.1m
Other Non-Current Liabilities 109m
Efficiency

Earnings Waterfall
Embla Medical hf

Revenue
840.3m USD
Cost of Revenue
-319.2m USD
Gross Profit
521.1m USD
Operating Expenses
-415.2m USD
Operating Income
105.9m USD
Other Expenses
-36.9m USD
Net Income
69.1m USD

Free Cash Flow Analysis
Embla Medical hf

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

EMBLA Profitability Score
Profitability Due Diligence

Embla Medical hf's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Revenue Growth Forecast
Positive 3-Years Revenue Growth
54/100
Profitability
Score

Embla Medical hf's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

EMBLA Solvency Score
Solvency Due Diligence

Embla Medical hf's solvency score is 56/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Short-Term Solvency
Long-Term Solvency
56/100
Solvency
Score

Embla Medical hf's solvency score is 56/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

EMBLA Price Targets Summary
Embla Medical hf

Wall Street analysts forecast EMBLA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EMBLA is 38.99 DKK with a low forecast of 33.33 DKK and a high forecast of 43.05 DKK.

Lowest
Price Target
33.33 DKK
7% Downside
Average
Price Target
38.99 DKK
9% Upside
Highest
Price Target
43.05 DKK
20% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for EMBLA?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for EMBLA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Embla Medical hf Logo
Embla Medical hf

Country

Iceland

Industry

Health Care

Market Cap

15.3B DKK

Dividend Yield

0%

Description

Össur hf is a global orthopaedics company, which engages in the design, development, manufacture, and sale of non-invasive orthopedic products. The firm is active in the development and distribution of products in the fields of non-invasive prosthetics, medical braces and supports. The firm's business activities are divided into three business segment: The Prosthetics, its product portfolio includes a range of lower and upper limb prosthetic components; The Bracing & Supports, which offers the Unloader One range of knee braces that relieve pain from knee osteoarthritis, as well as the Unloader Hip which is designed to reduce pain by optimizing load dispersion for patients suffering from mild and moderate osteoarthritis of the hip; and The Patient Care, which operates a network of Patient Care clinics around the world, with each one catering to individual patients and their needs.

Contact

Reykjavik
Grjothals 5
+3545151300
www.emblamedical.com

IPO

2009-01-01

Employees

3 999

Officers

President & CEO
Mr. Sveinn Solvason
Founder
Mr. Ossur Kristinsson
Chief Financial Officer
Ms. Gudny Arna Sveinsdottir
Chief Operating Officer
Mr. Lukas Marklin
Investor Relations Director
Edda Lara Luovigsdottir
Executive Vice President of People, Strategy & Sustainability
Ms. Margret Lara Fridriksdottir
Show More
Chief Commercial Officer
Mr. Olafur Gylfason
Executive Vice President of EMEA & APAC
Mr. Gudjon G. Karason
President of Americas
Mr. Christian Robinson
Executive Vice President of Research & Development
Ms. Hildur Einarsdottir
Show Less

See Also

Discover More
What is the Intrinsic Value of one EMBLA stock?

The intrinsic value of one EMBLA stock under the Base Case scenario is 39.12 DKK.

Is EMBLA stock undervalued or overvalued?

Compared to the current market price of 35.9 DKK, Embla Medical hf is Undervalued by 8%.

Back to Top